Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-06-06
1991-06-04
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
560 1, 560 11, 560 17, 560 29, 560 30, 560 31, 560 32, 560 56, 560119, 560256, 560122, 560123, 560124, 560132, 560220, 560 61, 560 62, 560 63, 560227, 560228, 560107, 560184, 560187, 560188, 516206, A61K 31215, C07C 6922
Patent
active
050214535
ABSTRACT:
Compounds of formula (I) and (II): ##STR1## are HMG-CoA reductase inhibitors.
REFERENCES:
patent: 4361515 (1987-11-01), Teraharo et al.
patent: 4448979 (1984-05-01), Terahara et al.
patent: 4517373 (1985-05-01), Teharo et al.
patent: 4582915 (1986-04-01), Sleteiger et al.
patent: 4604472 (1986-08-01), Ide et al.
patent: 4733003 (1988-03-01), Ide et al.
patent: 4833258 (1989-05-01), Smith et al.
patent: 4857522 (1989-08-01), DiPietro et al.
Joshua Henry
Lee Ta J.
Schwartz Michael S.
Stokker Gerald E.
Wilson Kenneth E.
DiPrima Joseph F.
Merck & Co. , Inc.
Raymond Richard L.
Russell Mark W.
Winokur Melvin
LandOfFree
3-keto HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-keto HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-keto HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026803